The impact of infrared light therapy in acupuncture points on the severity of restless leg syndrome in patients undergoing hemodialysis

The survey of the impact of infrared light therapy based on acupuncture points on the severity of restless leg syndrome in patients undergoing hemodialysis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016112727779N3

Enrollment

Registered

2017-09-16

Start date

2017-09-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless leg syndrome. Other specified extrapyramidal and movement disorders

Interventions

Intervention 1: The intervention group: The intervention in this study is using the infrared light in the acupuncture points for two minutes and during 12 sessions (three times a week). Intervention 2

Rehabilitation

The intervention group: The intervention in this study is using the infrared light in the acupuncture points for two minutes and during 12 sessions (three times a week).

The control group: There is no intervention in the control group.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria: Informed consent for participation in the study; suffering from restless leg syndrome; the age range of 18 to 65 years. Exclusion criteria: Unwillingness to continue participating in the study; failure to take part in the light therapy sessions in more than three sessions; recent use of restless leg syndrome drugs; kidney transplant; immigration or death.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The severity of restless leg syndrome. Timepoint: Before the intervention, two weeks after the intervention, four weeks after the intervention, two weeks after the end of the intervention. Method of measurement: The standard questionnaire of the restless leg syndrome.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mehdi Mohammadi

Kermanshah University of Medical Sciences

mehdi20.mohamadi@gmail.com+98 83 3836 1129

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026